Pharvaris BV PHVS:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
33.61quote price arrow down-4.89 (-12.70%)
Volume
202,803
52 week range
23.06 - 42.86

...

Loading . . .

KEY STATS

  • Open38.25
  • Day High39.20
  • Day Low32.21
  • Prev Close38.50
  • 52 Week High42.86
  • 52 Week High Date02/22/21
  • 52 Week Low23.06
  • 52 Week Low Date02/05/21
  • Market Cap1.07B
  • Shares Out31.84M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.29
  • P/E (TTM)-114.01
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-22.538M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Pharvaris BV News

There is no recent news for this security.

Latest PHVS News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Pharvaris BV is a Switzerland-based clinical-stage company. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).
Berndt Modig
Chief Executive Officer
Address
J.H. Oortweg 21
Leiden
2333 CH
Netherlands